Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: Prognostic value in adults with early-stage disease

Journal of Infectious Diseases

Volumn 186, Issue 8, 2002, Pages 1181-1185

  Sterling, Timothy R ^a,b   Hoover, Donald R ^c   Astemborski, Jacquie ^a,b   Vlahov, David ^a,b,d   Bartlett, John G ^a   Schupbach, Jorg ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d NEW YORK ACADEMY OF MEDICINE   (United States)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD LEVEL; CORRELATION COEFFICIENT; COST BENEFIT ANALYSIS; DISEASE COURSE; HEAT TREATMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DENATURATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAT; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; PROGNOSIS; PROTEIN DENATURATION; RNA, VIRAL;

EID: 0037108665     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/343807     Document Type: Article

References (15)

1. UNAIDS. Report on the global HIV/AIDS epidemic (June 2000). Geneva: Joint United Nations Programme on HIV/AIDS, 2000.
2. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
3. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Panel on Clinical Practices for Treatment of HIV Infection. Ann Intern Med 2002; 137:381-433.
4. Ledergerber B, Flepp M, Boni J, et al. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis 2000;181:1280-7.
5. Boni J, Opravil M, Tomasik Z, et al. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted ELISA for heat-denatured plasma. AIDS 1997;11:F47-52.
6. Spector SA, Kennedy C, McCutchan JA, et al. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. J Infect Dis 1989; 159:822-8.
7. MacDonell KB, Chmiel JS, Poggensee L, Wu S, Phair JP. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med 1990;89:706-12.
8. Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection. Ann Intern Med 2001;134:25-9.
9. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991;109:75-100.
10. Vlahov D, Graham N, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users. JAMA 1998;279:35-40.
11. Ginocchio CC, Wang XP, Kaplan MH, et al. Effects of specimen collection, processing, and storage conditions on the stability of human immunodeficiency virus type I RNA levels in plasma. J Clin Microbiol 1997;35: 2886-93.
12. Lathey JL, Marchsner IC, Kabat B, Spector SA. Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing. J Clin Microbiol 1997;35:631-5.
13. Burgisser P, Vernazza P, Flepp M, et al. Performance of five different assays for the quantification of viral load in subjects infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2000; 23:138-44.
14. Brown C, Kline R, Atibu L, Francis H, Ryder R, Quinn TC. Prevalence of HIV-1 p24 antigenemia in African and North American populations and correlation with clinical status. AIDS 1991;5:89-92.
15. Lyamuya E, Bredberg-Raden U, Massawe A, et al. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12: 421-6.